XBiotech (XBIT)

• Market cap: $82.3M
• 1 day: -1.82%
• 5 days: -2.88%
• 1 month: -14.29%
• 3 months: -1.46%
• 6 months: -23.3%
• Year to date: -35.25%
• 1 year: -61.86%
• 5 years: -86.38%
• 10 years: -85.22%
• Sector: Healthcare
• Industry: Biotechnology

About: XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Employees: 92

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

3.48% less ownership

Funds ownership: 14.69% [Q1] → 11.2% (-3.48%) [Q2]

5% less funds holding

Funds holding: 55 [Q1] → 52 (-3) [Q2]

17% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 18

30% less capital invested

Capital invested by funds: $14.5M [Q1] → $10.1M (-$4.36M) [Q2]

37% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 19

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K